BMC Health Services Research

Table 5 Retail price of antimalarials per adult equivalent treatment dose in drug stores by area^a

From: An assessment of the malaria-related knowledge and practices of Tanzania’s drug retailers: exploring the impact of drug store accreditation

	ADDO regions		Non-ADDO regions
	N	Median Price [IQR]	N	Median Price [IQR]
Artemether lumefantrine
Subsidised^b tablets	180	0.83 [0.62–1.25]	150	0.94 [0.83-1.25]*
Unsubsidised tablets	15	1.00 [0.62-1.25]	7	1.25 [1.00-6.25]*
Unsubsidised non-tablets	5	16.66 [15.00-16.66]	14	16.66 [15.00 – 16.66]
Other ACTs
Tablets	48	6.25 [3.12-12.50]	87	6.25 [3.12-11.52]
Non-tablets	0	–	2	28.75 [20.00-37.50]
Artemisinin monotherapies
Non-tablets^c	1	22.50	0	–
Non-artemisinin therapies
Tablets	387	0.94 [0.62-1.31]	376	0.75 [0.56-0.94]
Non-tablets	268	3.57 [2.81-21.97]	289	2.81 [1.87-16.48]*

*denotes p < 0.05
^aPrices given in 2010 USD equivalent
^bArtemeter lumefantrine was identified as subsidised if it bore the AMFm green leaf logo on its packaging
^cNo oral artemisinin monotherapies were recorded in drug stores

Back to article page

ISSN: 1472-6963

Contact us

General enquiries: journalsubmissions@springernature.com